RELIEVE: Research on Effectiveness of Surgery and Radiotherapy on Relieving Spine Tumor Pain in Patients with Vertebral Metastases
RELIEVE
RELIEVE Research on Effectiveness of Surgery and Radiotherapy on Relieving Spine Tumor Pain in Patients with Vertebral Metastases
1 other identifier
observational
250
0 countries
N/A
Brief Summary
This is a prospective, multicenter, observational study focusing on assessing and managing pain in patients with metastatic spinal tumors. Pain from spinal metastases adversely impacts quality of life, function, and treatment outcomes. Advances in surgical techniques have shown significant benefits. However, previous studies either lacked nuanced differentiations or simply categorized pain as mechanical or non-mechanical; explaining the highly variable pain outcome measurements in these studies. This study employs the AO Spine Cancer-Related Pain Classification to better categorize neoplastic spinal pain by etiology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2025
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2024
CompletedFirst Posted
Study publicly available on registry
December 24, 2024
CompletedStudy Start
First participant enrolled
March 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2027
December 24, 2024
December 1, 2024
2.7 years
December 11, 2024
December 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Pain intensity on the Brief Pain Inventory Intensity Scale of four different types of pain caused by the index spinal metastasis, measuring pain on a numeric rating scale from 0 to 10, with 0 meaning no pain and 10 meaning as bad as one can imagine.
The primary study outcome is the intensity of the four different types of pain caused by the index spinal metastasis, ie, the index pain(s): * Axial non-triggered pain * Axial triggered/mechanical pain * Radicular non-triggered pain * Radicular triggered/mechanical pain
Baseline and 3 months
Secondary Outcomes (33)
Patient Reported Outcome Measure: Michigan Body Map measuring pain location
Baseline, 1 month, 3 months, and 6 months
Patient Reported Outcome Measure: PainDETECT measuring neuropathic pain
Baseline, 1 month, 3 months, and 6 months.
Patient Reported Outcome Measure: BAT measuring breakthrough pain
Baseline, 1 month, 3 months, and 6 months.
Patient Reported Outcome Measure: PROMIS Bank v1.0-Fatigue measuring fatigue
Baseline, 1 month, 3 months, and 6 months.
Patient Reported Outcome Measure: PROMIS Bank v2.0-Physical Function measuring physical function
Baseline, 1 month, 3 months, and 6 months.
- +28 more secondary outcomes
Interventions
Surgery may be instrumented stabilization surgery alone, instrumented stabilization and decompression, or decompression surgery alone.
Eligibility Criteria
Adult patients with metastatic spinal tumors as per eligibility criteria.
You may qualify if:
- Age 18 years and older
- Patients diagnosed with metastatic spinal tumors with one index metastatic site that, confirmed by the treating clinicians, is causing spine pain
- Patients experience at least one type of pain that is of interest of this study, namely, axial non-triggered pain, axial triggered/mechanical pain, radicular non-triggered pain, and radicular triggered/mechanical pain
- At least one type of the pain experienced has an NRS \> 4 of 10
- Patients undergoing surgery and/or radiotherapy
- Surgery may be instrumented stabilization surgery alone, instrumented stabilization and decompression, or decompression surgery alone.
- Percutaneous screw fixation counts as instrumented stabilization surgery.
- Any kind of radiotherapy is includable.
- Ability to provide informed consent according to the IRB/EC defined and approved procedures
You may not qualify if:
- Estimated survival \< 3 months
- Patients with more than one symptomatic spine metastasis site
- o An example is a patient with two metastasis sites: a lumbar metastasis (causing vertebral fracture and epidural compression leading to mechanical lower back pain and static radicular pain to legs) and a cervical metastasis (causing tumor-related pain at the neck).
- Patients with other sources of pain that may confound the measurement of the primary outcome
- o An example is a patient with liver metastasis which causes visceral pain that can confound the thoracic spinal pain caused by the spinal metastasis.
- Cement augmentation, vertebroplasty, kyphoplasty, and other emerging interventions such as local ablative technique
- Chemotherapy or systemic therapy alone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 11, 2024
First Posted
December 24, 2024
Study Start
March 31, 2025
Primary Completion (Estimated)
November 30, 2027
Study Completion (Estimated)
November 30, 2027
Last Updated
December 24, 2024
Record last verified: 2024-12